A detailed history of Balyasny Asset Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 245,110 shares of DYN stock, worth $5.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
245,110
Holding current value
$5.88 Million
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.94 - $47.04 $7.83 Million - $11.5 Million
245,110 New
245,110 $8.8 Million
Q3 2023

Nov 14, 2023

BUY
$8.6 - $12.18 $151,755 - $214,928
17,646 New
17,646 $158,000
Q2 2022

Aug 15, 2022

BUY
$4.36 - $10.5 $431,055 - $1.04 Million
98,866 New
98,866 $679,000
Q3 2021

Nov 15, 2021

SELL
$15.6 - $21.46 $3.04 Million - $4.19 Million
-195,052 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$15.94 - $22.33 $3.11 Million - $4.36 Million
195,052 New
195,052 $4.1 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.